Neuron-related blood inflammatory markers as an objective evaluation tool for major depressive disorder

An exploratory pilot case-control study

Nobuki Kuwano, Takahiro Kato, Masato Mitsuhashi, Mina Sato-Kasai, Norihiro Shimokawa, Kohei Hayakawa, Masahiro Ohgidani, Noriaki Sagata, Hiroaki Kubo, Takeshi Sakurai, Shigenobu Kanba

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Neuroinflammation is suggested to be a crucial factor in the pathophysiology of major depressive disorder (MDD). Analysis of neuron-derived exosomes (NDE) in peripheral blood has recently been highlighted to reveal the pathophysiology of brain diseases without using brain biopsy. Currently, human NDE studies require a considerable amount of peripheral blood to measure multiple substances inside exosomes. Previously, NDE-based clinical studies focusing on MDD have not been reported. Methods: As an exploratory pilot case-control study between healthy controls (HC) and drug-free MDD patients (each; N = 34), we searched for NDE-related blood biomarkers with a small amount of peripheral blood using a novel sandwich immunoassay between anti-neuron antibody and antibodies against CD81 (an exosome marker) and against other proteins related to neuroinflammation and synaptic functions. Results: Most neuron-related blood biomarkers had moderately to strongly positive correlation with CD81 (NDE), thus we normalized the above biomarkers by CD81 (quantity of each biomarker/CD81) to predict NDE-related blood substances. Interleukin 34 (IL34)/CD81 levels were significantly higher in MDD group compared to HC group. Synaptophysin (SYP), SYP/CD81, and tumor necrosis factor receptor 1 (TNFR1)/CD81 were positively correlated with severities of depression and/or various sub-symptoms. Limitations: We did not actually extract NDE from peripheral blood. Conclusions: Using a small amount of peripheral blood, we have successfully detected possible NDE-related blood biomarkers. This is the first study to suggest that not only SYP and TNFR1 but also IL34 are important blood biomarkers for patients with MDD. Further studies are warranted to evaluate the present study.

Original languageEnglish
Pages (from-to)88-98
Number of pages11
JournalJournal of Affective Disorders
Volume240
DOIs
Publication statusPublished - Nov 1 2018

Fingerprint

Exosomes
Major Depressive Disorder
Case-Control Studies
Neurons
Biomarkers
Synaptophysin
Tumor Necrosis Factor Receptors
Drug and Narcotic Control
Interleukins
Brain Diseases
Interleukin-1
Immunoassay
Anti-Idiotypic Antibodies
Depression

All Science Journal Classification (ASJC) codes

  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

Neuron-related blood inflammatory markers as an objective evaluation tool for major depressive disorder : An exploratory pilot case-control study. / Kuwano, Nobuki; Kato, Takahiro; Mitsuhashi, Masato; Sato-Kasai, Mina; Shimokawa, Norihiro; Hayakawa, Kohei; Ohgidani, Masahiro; Sagata, Noriaki; Kubo, Hiroaki; Sakurai, Takeshi; Kanba, Shigenobu.

In: Journal of Affective Disorders, Vol. 240, 01.11.2018, p. 88-98.

Research output: Contribution to journalArticle

Kuwano, N, Kato, T, Mitsuhashi, M, Sato-Kasai, M, Shimokawa, N, Hayakawa, K, Ohgidani, M, Sagata, N, Kubo, H, Sakurai, T & Kanba, S 2018, 'Neuron-related blood inflammatory markers as an objective evaluation tool for major depressive disorder: An exploratory pilot case-control study', Journal of Affective Disorders, vol. 240, pp. 88-98. https://doi.org/10.1016/j.jad.2018.07.040
Kuwano, Nobuki ; Kato, Takahiro ; Mitsuhashi, Masato ; Sato-Kasai, Mina ; Shimokawa, Norihiro ; Hayakawa, Kohei ; Ohgidani, Masahiro ; Sagata, Noriaki ; Kubo, Hiroaki ; Sakurai, Takeshi ; Kanba, Shigenobu. / Neuron-related blood inflammatory markers as an objective evaluation tool for major depressive disorder : An exploratory pilot case-control study. In: Journal of Affective Disorders. 2018 ; Vol. 240. pp. 88-98.
@article{cef1fb8f05874bf4a192fa7815c8c0b3,
title = "Neuron-related blood inflammatory markers as an objective evaluation tool for major depressive disorder: An exploratory pilot case-control study",
abstract = "Background: Neuroinflammation is suggested to be a crucial factor in the pathophysiology of major depressive disorder (MDD). Analysis of neuron-derived exosomes (NDE) in peripheral blood has recently been highlighted to reveal the pathophysiology of brain diseases without using brain biopsy. Currently, human NDE studies require a considerable amount of peripheral blood to measure multiple substances inside exosomes. Previously, NDE-based clinical studies focusing on MDD have not been reported. Methods: As an exploratory pilot case-control study between healthy controls (HC) and drug-free MDD patients (each; N = 34), we searched for NDE-related blood biomarkers with a small amount of peripheral blood using a novel sandwich immunoassay between anti-neuron antibody and antibodies against CD81 (an exosome marker) and against other proteins related to neuroinflammation and synaptic functions. Results: Most neuron-related blood biomarkers had moderately to strongly positive correlation with CD81 (NDE), thus we normalized the above biomarkers by CD81 (quantity of each biomarker/CD81) to predict NDE-related blood substances. Interleukin 34 (IL34)/CD81 levels were significantly higher in MDD group compared to HC group. Synaptophysin (SYP), SYP/CD81, and tumor necrosis factor receptor 1 (TNFR1)/CD81 were positively correlated with severities of depression and/or various sub-symptoms. Limitations: We did not actually extract NDE from peripheral blood. Conclusions: Using a small amount of peripheral blood, we have successfully detected possible NDE-related blood biomarkers. This is the first study to suggest that not only SYP and TNFR1 but also IL34 are important blood biomarkers for patients with MDD. Further studies are warranted to evaluate the present study.",
author = "Nobuki Kuwano and Takahiro Kato and Masato Mitsuhashi and Mina Sato-Kasai and Norihiro Shimokawa and Kohei Hayakawa and Masahiro Ohgidani and Noriaki Sagata and Hiroaki Kubo and Takeshi Sakurai and Shigenobu Kanba",
year = "2018",
month = "11",
day = "1",
doi = "10.1016/j.jad.2018.07.040",
language = "English",
volume = "240",
pages = "88--98",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",

}

TY - JOUR

T1 - Neuron-related blood inflammatory markers as an objective evaluation tool for major depressive disorder

T2 - An exploratory pilot case-control study

AU - Kuwano, Nobuki

AU - Kato, Takahiro

AU - Mitsuhashi, Masato

AU - Sato-Kasai, Mina

AU - Shimokawa, Norihiro

AU - Hayakawa, Kohei

AU - Ohgidani, Masahiro

AU - Sagata, Noriaki

AU - Kubo, Hiroaki

AU - Sakurai, Takeshi

AU - Kanba, Shigenobu

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Background: Neuroinflammation is suggested to be a crucial factor in the pathophysiology of major depressive disorder (MDD). Analysis of neuron-derived exosomes (NDE) in peripheral blood has recently been highlighted to reveal the pathophysiology of brain diseases without using brain biopsy. Currently, human NDE studies require a considerable amount of peripheral blood to measure multiple substances inside exosomes. Previously, NDE-based clinical studies focusing on MDD have not been reported. Methods: As an exploratory pilot case-control study between healthy controls (HC) and drug-free MDD patients (each; N = 34), we searched for NDE-related blood biomarkers with a small amount of peripheral blood using a novel sandwich immunoassay between anti-neuron antibody and antibodies against CD81 (an exosome marker) and against other proteins related to neuroinflammation and synaptic functions. Results: Most neuron-related blood biomarkers had moderately to strongly positive correlation with CD81 (NDE), thus we normalized the above biomarkers by CD81 (quantity of each biomarker/CD81) to predict NDE-related blood substances. Interleukin 34 (IL34)/CD81 levels were significantly higher in MDD group compared to HC group. Synaptophysin (SYP), SYP/CD81, and tumor necrosis factor receptor 1 (TNFR1)/CD81 were positively correlated with severities of depression and/or various sub-symptoms. Limitations: We did not actually extract NDE from peripheral blood. Conclusions: Using a small amount of peripheral blood, we have successfully detected possible NDE-related blood biomarkers. This is the first study to suggest that not only SYP and TNFR1 but also IL34 are important blood biomarkers for patients with MDD. Further studies are warranted to evaluate the present study.

AB - Background: Neuroinflammation is suggested to be a crucial factor in the pathophysiology of major depressive disorder (MDD). Analysis of neuron-derived exosomes (NDE) in peripheral blood has recently been highlighted to reveal the pathophysiology of brain diseases without using brain biopsy. Currently, human NDE studies require a considerable amount of peripheral blood to measure multiple substances inside exosomes. Previously, NDE-based clinical studies focusing on MDD have not been reported. Methods: As an exploratory pilot case-control study between healthy controls (HC) and drug-free MDD patients (each; N = 34), we searched for NDE-related blood biomarkers with a small amount of peripheral blood using a novel sandwich immunoassay between anti-neuron antibody and antibodies against CD81 (an exosome marker) and against other proteins related to neuroinflammation and synaptic functions. Results: Most neuron-related blood biomarkers had moderately to strongly positive correlation with CD81 (NDE), thus we normalized the above biomarkers by CD81 (quantity of each biomarker/CD81) to predict NDE-related blood substances. Interleukin 34 (IL34)/CD81 levels were significantly higher in MDD group compared to HC group. Synaptophysin (SYP), SYP/CD81, and tumor necrosis factor receptor 1 (TNFR1)/CD81 were positively correlated with severities of depression and/or various sub-symptoms. Limitations: We did not actually extract NDE from peripheral blood. Conclusions: Using a small amount of peripheral blood, we have successfully detected possible NDE-related blood biomarkers. This is the first study to suggest that not only SYP and TNFR1 but also IL34 are important blood biomarkers for patients with MDD. Further studies are warranted to evaluate the present study.

UR - http://www.scopus.com/inward/record.url?scp=85050540084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050540084&partnerID=8YFLogxK

U2 - 10.1016/j.jad.2018.07.040

DO - 10.1016/j.jad.2018.07.040

M3 - Article

VL - 240

SP - 88

EP - 98

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

ER -